Evofem CEO Demands Overhaul of Women’s Health at Fierce JPM Week 2026

Reuters
01/26
Evofem CEO Demands Overhaul of Women’s Health at Fierce <a href="https://laohu8.com/S/JPM">JPM</a> Week 2026

Evofem Biosciences Inc. CEO Saundra Pelletier delivered a powerful keynote address at Fierce JPM Week 2026, calling for a fundamental reset in women’s health. Pelletier highlighted the historical neglect of women’s health issues, stating, “If men suffered from endometriosis, it would be solved by now,” and criticized the exclusion of women from clinical trials due to perceptions about hormonal complexity. She emphasized Evofem’s commitment to prioritizing transparency, education, and respect in their approach to women’s health. The full keynote, titled “Rebuilding Women’s Health from the Ground Up,” is available for on-demand viewing via Fierce Pharma. Register for Fierce JPM Week 2026 and scroll to "Friday, January 23" to access the session.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evofem Biosciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260123678836) on January 23, 2026, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10